Deutsche Bank Aktiengesellschaft reaffirmed their hold rating on shares of Healthpeak Properties (NYSE:DOC - Free Report) in a report issued on Wednesday, Marketbeat Ratings reports. They currently have a $18.00 price objective on the real estate investment trust's stock, down from their prior price objective of $28.00.
DOC has been the subject of several other reports. Wedbush lowered their price target on shares of Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a research note on Monday, April 28th. Wells Fargo & Company lowered their price target on shares of Healthpeak Properties from $22.00 to $20.00 and set an "equal weight" rating for the company in a research note on Monday, June 2nd. Scotiabank cut shares of Healthpeak Properties from a "sector outperform" rating to a "sector perform" rating and decreased their price objective for the company from $21.00 to $19.00 in a research report on Tuesday, July 29th. Wall Street Zen cut shares of Healthpeak Properties from a "hold" rating to a "sell" rating in a research report on Monday, July 7th. Finally, Argus restated a "buy" rating and issued a $25.00 price objective on shares of Healthpeak Properties in a research report on Tuesday, April 29th. Seven investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $21.70.
Check Out Our Latest Research Report on DOC
Healthpeak Properties Trading Up 2.6%
Healthpeak Properties stock traded up $0.4450 during mid-day trading on Wednesday, hitting $17.7250. The company's stock had a trading volume of 8,696,799 shares, compared to its average volume of 8,563,543. The company has a debt-to-equity ratio of 1.06, a current ratio of 1.28 and a quick ratio of 1.28. The stock has a market cap of $12.32 billion, a price-to-earnings ratio of 73.86, a price-to-earnings-growth ratio of 2.20 and a beta of 1.05. The business has a 50 day moving average price of $17.62 and a 200-day moving average price of $18.38. Healthpeak Properties has a 12 month low of $16.63 and a 12 month high of $23.26.
Healthpeak Properties (NYSE:DOC - Get Free Report) last posted its quarterly earnings results on Thursday, July 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, hitting the consensus estimate of $0.46. The business had revenue of $694.35 million during the quarter, compared to the consensus estimate of $697.14 million. Healthpeak Properties had a net margin of 5.90% and a return on equity of 1.85%. The firm's revenue for the quarter was down .2% on a year-over-year basis. During the same period in the previous year, the firm posted $0.45 earnings per share. Healthpeak Properties has set its FY 2025 guidance at 1.810-1.870 EPS. As a group, analysts forecast that Healthpeak Properties will post 1.86 EPS for the current year.
Healthpeak Properties Dividend Announcement
The business also recently declared a dividend, which will be paid on Friday, August 29th. Investors of record on Tuesday, August 19th will be given a dividend of $0.1017 per share. The ex-dividend date is Monday, August 18th. This represents a dividend yield of 705.0%. Healthpeak Properties's payout ratio is currently 508.33%.
Insider Activity
In other news, CEO Scott M. Brinker bought 2,930 shares of the company's stock in a transaction dated Thursday, July 31st. The shares were purchased at an average price of $17.06 per share, for a total transaction of $49,985.80. Following the completion of the purchase, the chief executive officer owned 210,416 shares in the company, valued at approximately $3,589,696.96. This represents a 1.41% increase in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Tommy G. Thompson bought 5,777 shares of the company's stock in a transaction dated Wednesday, May 28th. The stock was purchased at an average price of $17.27 per share, for a total transaction of $99,768.79. Following the purchase, the director owned 144,290 shares of the company's stock, valued at approximately $2,491,888.30. This represents a 4.17% increase in their position. The disclosure for this purchase can be found here. Insiders have purchased 14,560 shares of company stock worth $249,898 in the last quarter. 0.23% of the stock is owned by corporate insiders.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. TCTC Holdings LLC increased its holdings in Healthpeak Properties by 124.3% during the first quarter. TCTC Holdings LLC now owns 1,355 shares of the real estate investment trust's stock valued at $27,000 after buying an additional 751 shares during the last quarter. Brooklyn Investment Group increased its holdings in Healthpeak Properties by 198.9% during the first quarter. Brooklyn Investment Group now owns 1,312 shares of the real estate investment trust's stock valued at $27,000 after buying an additional 873 shares during the last quarter. Rexford Capital Inc. purchased a new stake in Healthpeak Properties during the second quarter valued at approximately $28,000. Future Financial Wealth Managment LLC purchased a new stake in Healthpeak Properties during the first quarter valued at approximately $30,000. Finally, S.A. Mason LLC increased its holdings in Healthpeak Properties by 160.9% during the first quarter. S.A. Mason LLC now owns 1,500 shares of the real estate investment trust's stock valued at $30,000 after buying an additional 925 shares during the last quarter. Institutional investors own 93.57% of the company's stock.
About Healthpeak Properties
(
Get Free Report)
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
See Also

Before you consider Healthpeak Properties, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Healthpeak Properties wasn't on the list.
While Healthpeak Properties currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.